Skip to content

Opening book details…

Can I read Articles: Background on EtoBox?

Articles: Background by usmleusmle86 is a document available to read on EtoBox.

What is Articles: Background about?

A phase 3b trial evaluated the efficacy and safety of gefapixant in reducing cough-induced stress urinary incontinence (CSUI) in women with chronic cough. The study found that gefapixant significantly reduced CSUI episodes compared to placebo, with a treatment difference of -11.7% (p=0.004) and a majority of participants experiencing at least one adverse event. This indicates gefapixant is the first treatment to demonstrate efficacy in this specific patient population, addressing a significant unmet medical

Author
usmleusmle86
Language
EN